TMCnet News
Research and Markets: Bone Fracture - Pipeline Review, H2 2013 Research ReportDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/ztg2gl/bone_fracture) has announced the addition of the "Bone Fracture - Pipeline Review, H2 2013" report to their offering. 'Bone Fracture - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bone Fracture, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bone Fracture. Scope - A snapshot of the global therapeutic scenario for Bone Fracture. - A review of the Bone Fracture products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of montherapy and combined therapeutics. - Coverage of the Bone Fracture pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Bone Fracture Overview Therapeutics Development Pipeline Products for Bone Fracture - Overview Pipeline Products for Bone Fracture - Comparative Analysis Bone Fracture - Therapeutics under Development by Companies Bone Fracture - Therapeutics under Investigation by Universities/Institutes Bone Fracture - Pipeline Products Glance Clinical Stage Products Early Stage Products Bone Fracture - Products under Development by Companies Bone Fracture - Products under Investigation by Universities/Institutes Bone Fracture - Companies Involved in Therapeutics Development Bone Fracture - Therapeutics Assessment Drug Profiles KCB-1B - Drug Profile Allogeneic Stem Cells - Drug Profile AZD-2858 - Drug Profile Bone Regeneration Project - Drug Profile JVS-200 - Drug Profile denosumab biosimilar - Drug Profile Calcitonin Receptor Peptide - Drug Profile 17Beta-HSD2 Inhibitors - Drug Profile Recombinant BMP-2 Biosimilar - Drug Profile Nitric Oxide Synthase Antagonist - Drug Profile Appendix Companies Mentioned AstraZeneca PLC Kaken Pharmaceutical Co., Ltd. Juventas Therapeutics, Inc. Laboratorios SALVAT S.A. ElexoPharm GmbH Bone Therapeutics SA bioXPRESS Therapeutics SA Biogenomics For more information visit http://www.researchandmarkets.com/research/ztg2gl/bone_fracture About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
|